Trials / Completed
CompletedNCT01411696
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 289 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone intravitreal implant 0.7 mg | Dexamethasone intravitreal implant 0.7 mg was dosed previously according to general clinical practice. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-08-08
- Last updated
- 2013-04-16
- Results posted
- 2013-04-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01411696. Inclusion in this directory is not an endorsement.